The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A novel therapeutic strategy for effective elimination of glioblastoma stem cells using biochemical mechanism-based drug combinations.
S. Yuan
No relevant relationships to disclose
F. Wang
No relevant relationships to disclose
L. Wang
No relevant relationships to disclose
H. Zhang
No relevant relationships to disclose
G. Chen
No relevant relationships to disclose
L. Feng
No relevant relationships to disclose
R. Xu
No relevant relationships to disclose
J. Wang
No relevant relationships to disclose
P. Huang
No relevant relationships to disclose